
Default

Allergy and immunology

Anaesthesia

Basic research

Cardiovascular medicine

Complementary medicine and alternative therapies

Critical care / intensive care

Dentistry / oral medicine

Dermatology

Emergency medicine

Endocrinology

Epidemiology

Ethics

Evidence-based medicine

Gastroenterology

Genetics

Geriatric medicine / aging

Haematology / blood transfusion

Health economics

Health policy

History of medicine

Infectious diseases

Internal medicine

Laboratory medicine

Legal and forensic medicine

Medical education

Medical informatics

Neurology

Nursing

Nutrition and metabolism

Obstetrics and gynaecology

Occupational and environmental medicine

Oncology

Ophthalmology

Organisation of health care

Otolaryngology / head and neck surgery

Paediatrics

Palliative care

Pathology

Patient-physician relationship

Pharmacology and therapeutics

Primary care, family medicine

Psychiatry and psychotherapy

Psychosomatics

Public health

Quality of care

Radiology

Rehabilitation medicine

Renal medicine

Respiratory medicine

Rheumatology

Sexual medicine

Sports medicine

Statistics and research methods

Surgery

Transplantation

Travel medicine

Urology
Towards novel reimbursement models for expensive advanced therapy medicinal products (ATMPs)
This article analyses the current legal framework in Switzerland and critically evaluates existing reimbursement models, particularly with respect to their adaptation for advanced therapy medicinal products. As a promising reimbursement arrangement, this paper proposes a model combining outcome-based instalment payments with aspects of the pay for performance and the annuity payment model.
Optimal allocation of limited test resources for the quantification of COVID-19 infections
The proposed methodology can lead to vastly less uncertain predictions for the spread of the disease, thus improving estimates of the effective reproduction number and the future number of unreported infections. This information can provide timely and systematic guidance for the effective identification of infectious individuals and for decision-making regarding lockdown measures and the distribution of vaccines.
Hepatitis C micro-elimination among people on opioid agonist therapy is a low-hanging fruit
People who use drugs are badly affected by chronic hepatitis C. As a result of the pragmatic national drug policy in Switzerland, the majority of persons with an opioid dependency are on opioid agonist therapy (OAT) and therefore in the healthcare system. For years, national guidelines have recommended that all OAT patients be regularly tested for hepatitis C and, if tested positive, referred for treatment.
Response of a European surgical department to the COVID-19 crisis
At first sight, surgery appears to be only peripherally affected by the COVID.19 pandemic. However, the surgical department plays a key role in the response to this crisis. This article aims to provide a blueprint for a general surgery department’s response to this current pandemic crisis and also future events of similar magnitude.
COVID-19 and Iran: swimming with hands tied!
Like many other countries around the world, Iran is contending with the COVID-19 epidemic, but with the additional burden of international sanctions on supplies of medicines and medical equipment.
Diagnostic diversity – an indicator of institutional and regional healthcare quality
The diagnostic diversity index can be seen as an indicator of diagnostic precision - the higher the degree of diversity, the better the diagnostic precision.
Dual use in the 21st century: emerging risks and global governance
Dual use risks in the second decade of the 21st century are characterised by: diversification of dual use domains, digitalisation of potential threats, and the proliferation of actors.
A buyers’ club to improve access to hepatitis C treatment for vulnerable populations
High costs are an important barrier to treatment access for vulnerable and often uninsured patients with hepatitis C.
Predictors for shorter and longer length of hospital stay outliers: a retrospective case-control study of 8247 patients at a university hospital trauma department
Providing efficient healthcare is important for hospitals. Shorter and longer length of hospital stay (LOS) outliers influence financial results and reimbursement.
The inconsistent ethical oversight of healthcare quality data in Switzerland
Further consideration needs to be given to how regulations can be revised in a way that ensures that healthcare improvement activities using the same quality data in Switzerland are not either overregulated on one side or completely without control on the other.